Literature DB >> 15931537

[Early recognition and intervention for schizophrenia].

N Mossaheb1, G Wiesegger, G P Amminger, S Kasper, J Tauscher.   

Abstract

Studies dealing with the prodromal stage of schizophrenia point to the possibility of early detection and early intervention. Major socioeconomic and social consequences are associated with this disorder. The duration of untreated psychosis seems to play an important role in the course of the disease; i.e. a prolonged duration until adequate treatment is obtained correlates to poorer prognosis. Social, cognitive, affective, and structural brain variations appear in the early prodromal stage. Recent early intervention studies show the possibility of reducing transition rates by preventive treatment of patients at a higher risk of psychosis and already manifesting impaired function. In this review, prodromal signs and possibilities for early detection and intervention in schizophrenia are presented.

Entities:  

Mesh:

Year:  2006        PMID: 15931537     DOI: 10.1007/s00115-005-1925-6

Source DB:  PubMed          Journal:  Nervenarzt        ISSN: 0028-2804            Impact factor:   1.214


  66 in total

1.  Benefit-risk evaluation of olanzapine, risperidone and sertindole in the treatment of schizophrenia.

Authors:  S Kasper; A Hale; J M Azorin; H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1999       Impact factor: 5.270

2.  Duration of untreated psychosis predicts treatment outcome in an early psychosis program.

Authors:  K Black; L Peters; Q Rui; H Milliken; D Whitehorn; L C Kopala
Journal:  Schizophr Res       Date:  2001-03-01       Impact factor: 4.939

3.  Early intervention in schizophrenia.

Authors:  M Birchwood; P McGorry; H Jackson
Journal:  Br J Psychiatry       Date:  1997-01       Impact factor: 9.319

4.  [The concept of substrate-close basic symptoms and its significance for the theory and therapy of schizophrenic diseases].

Authors:  G Huber
Journal:  Nervenarzt       Date:  1983-01       Impact factor: 1.214

5.  Premorbid neuropathology in schizophrenia.

Authors:  D R Weinberger
Journal:  Lancet       Date:  1988-08-20       Impact factor: 79.321

6.  Risperidone olanzapine drug outcomes studies in schizophrenia (RODOS): efficacy and tolerability results of an international naturalistic study.

Authors:  S Kasper; D Rosillon; I Duchesne
Journal:  Int Clin Psychopharmacol       Date:  2001-07       Impact factor: 1.659

7.  Predictors and outcome characteristics associated with suicidal behaviour in early psychosis: a two-year follow-up of first-admitted subjects.

Authors:  H Verdoux; F Liraud; B Gonzales; F Assens; F Abalan; J van Os
Journal:  Acta Psychiatr Scand       Date:  2001-05       Impact factor: 6.392

8.  Diagnosing schizophrenia in the initial prodromal phase.

Authors:  J Klosterkötter; M Hellmich; E M Steinmeyer; F Schultze-Lutter
Journal:  Arch Gen Psychiatry       Date:  2001-02

9.  Duration of untreated psychosis and cognitive deterioration in first-episode schizophrenia.

Authors:  G P Amminger; J Edwards; W J Brewer; S Harrigan; P D McGorry
Journal:  Schizophr Res       Date:  2002-04-01       Impact factor: 4.939

10.  Untreated initial psychosis: relation to cognitive deficits and brain morphology in first-episode schizophrenia.

Authors:  Beng-Choon Ho; Daniel Alicata; Julianna Ward; David J Moser; Daniel S O'Leary; Stephan Arndt; Nancy C Andreasen
Journal:  Am J Psychiatry       Date:  2003-01       Impact factor: 18.112

View more
  1 in total

Review 1.  Which perspectives can endophenotypes and biological markers offer in the early recognition of schizophrenia?

Authors:  S Bender; M Weisbrod; F Resch
Journal:  J Neural Transm (Vienna)       Date:  2007-05-21       Impact factor: 3.575

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.